Inotek Pharmaceuticals Corp (ITEK): Billionaire Ken Griffin’ Citadel Investment Group Raises Stake to 6.5%

Page 8 of 10 – SEC Filing

 

Item 4

Ownership

A.

Citadel Advisors LLC

(a)

Citadel Advisors may be deemed to beneficially own 1,871,258 shares of common stock.

(b)

The number of shares Citadel Advisors may be deemed to beneficially own constitutes approximately 6.5% of the common stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 1,871,258

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 1,871,258

B.

Citadel Advisors Holdings II LP

(a)

CAH2 may be deemed to beneficially own 1,871,258 shares of common stock.

(b)

The number of shares CAH2 may be deemed to beneficially own constitutes approximately 6.5% of the common stock outstanding.

(c)

Number of shares as to which such person has:

(i)

sole power to vote or to direct the vote: 0

(ii)

shared power to vote or to direct the vote: 1,871,258

(iii)

sole power to dispose or to direct the disposition of: 0

(iv)

shared power to dispose or to direct the disposition of: 1,871,258